Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · July 02, 2015

Heart Failure Risk in Type 2 Diabetics on Oral Glucose-Lowering Medications

European Heart Journal

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Heart Journal
Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Newly Treated With DPP-4 Inhibitors or Other Oral Glucose-Lowering Medications: A Retrospective Registry Study on 127,555 Patients From the Nationwide OsMed Health-DB Database
Eur Heart J 2015 Jun 25;[EPub Ahead of Print], GP Fadini, A Avogaro, L Degli Esposti, P Russo, S Saragoni, S Buda, G Rosano, S Pecorelli, L Pani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading